ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Dakota » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in South Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TOMASZ STYS M.D.

Cardiovascular Disease

9,039

$437K

893
804 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 21%

$48
Average prescription price

Avg: $73

LLOYD SOLBERG M.D.

Cardiovascular Disease

8,507

$298K

666
623 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$35
Average prescription price

Avg: $73

MARIAN PETRASKO M.D.

Cardiovascular Disease

8,440

$339K

881
788 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$40
Average prescription price

Avg: $73

ADAM STYS MD

Cardiovascular Disease

6,938

$311K

800
705 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $73

KEVIN VASKA MD

Cardiovascular Disease

5,572

$3.55M

381
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 21%

$637
Average prescription price

Avg: $73

SAMUEL DURR MD

Cardiovascular Disease

5,330

$279K

475
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 21%

$52
Average prescription price

Avg: $73

DREW PURDY MD

Cardiovascular Disease

4,814

$266K

430
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 21%

$55
Average prescription price

Avg: $73

ALEXANDER SCHABAUER MD

Cardiovascular Disease

4,746

$276K

298
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 21%

$58
Average prescription price

Avg: $73

LEWIS FERRIER MD

Cardiovascular Disease

4,520

$357K

384
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 21%

$79
Average prescription price

Avg: $73

RAYMOND ALLEN MD

Cardiovascular Disease

4,477

$291K

458
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 21%

$65
Average prescription price

Avg: $73

ORVAR JONSSON MD

Cardiovascular Disease

4,026

$233K

493
432 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$58
Average prescription price

Avg: $73

MICHAEL HIBBARD MD

Cardiovascular Disease

3,996

$139K

365
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$35
Average prescription price

Avg: $73

MICHAEL D'URSO MD

Cardiovascular Disease

3,859

$213K

363
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 21%

$55
Average prescription price

Avg: $73

K HEILMAN MD

Cardiovascular Disease

3,772

$290K

347
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 21%

$77
Average prescription price

Avg: $73

AMAD ZINELDINE MD

Cardiovascular Disease

3,645

$148K

312
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $73

DAVID NAGELHOUT MD

Cardiovascular Disease

3,582

$112K

367
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 21%

$31
Average prescription price

Avg: $73

WILLARD HURLEY MD

Cardiovascular Disease

3,503

$110K

337
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$31
Average prescription price

Avg: $73

BRUCE WATT MD

Cardiovascular Disease

3,459

$160K

393
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$46
Average prescription price

Avg: $73

TAREK MAHROUS MD

Cardiovascular Disease

3,388

$133K

364
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 21%

$39
Average prescription price

Avg: $73

JAMES WALDER MD

Cardiovascular Disease

3,320

$179K

287
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 21%

$54
Average prescription price

Avg: $73

GALEN VONK MD

Cardiovascular Disease

2,953

$134K

318
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $73

JERRY MOENCH MD

Cardiovascular Disease

2,916

$112K

283
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $73

C GAECKLE MD

Cardiovascular Disease

2,873

$102K

321
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$36
Average prescription price

Avg: $73

MARK GORDON MD

Cardiovascular Disease

2,675

$191K

299
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 21%

$72
Average prescription price

Avg: $73

PAUL CARPENTER MD

Cardiovascular Disease

2,671

$134K

316
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 21%

$50
Average prescription price

Avg: $73

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank